HONG KONG, Jan 10 (Reuters) - China's Shenzhen Kangtai Biological Products (300601.SZ), opens new tab reported a net loss in 2022, hurt by waning demand for COVID-19 vaccine shots. The decline from a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results